8-K
Current Report
Inhibitor Therapeutics, Inc. Filed Acc 0001193125-22-308415
Material agreement · Agreement ended · Change in control · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 5.01 Changes in control of the registrant
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d428971d8k.htm…